KDL Biotech Ltd. Company History and Annual Growth Details

YEAR EVENTS
2000 - The Union has declared a strike at the company's factory situated at Village
Savroli, Taluka Khalapur, Khopoli, Dist. Raigad, Maharashtra.

- The Company's major foray into the business of biotechnology based products
it was proposed to change the name of the Company from Kopran Drugs Limited
to KDL Biotech Limited for which necessary approval has been received from
Registrar of Companies, Maharashtra, Mumbai.

- The Company is a major producer of Semi-synthetic Penicillins (SSP) and the Enzyme
for converting Penicillin-G to 6APA.

- 71,50,110 Equity Shares of Rs.10/- each were allotted as fully paid-up as per the Scheme
of Arrangement (01-01-1998) to the Shareholders of Kopran Limited.

- 57,20,000 12% Optionally Convertible Cummulative Preference Shares of Rs.100/- each
were alloted as fully paid up as per the Scheme of Arrangement (01-01-1998) to Kopran Limited.

2001 - Crisil has downgraded the company's NCDs issue to `BB+' from `BBB'.

2002 - Mr. Nalin Bamzal and Mr. Vijay Bhatia have been appointed as Additional Directors on the Board.

2003

-The following directors have resigned from the Board of the company: 1. Mr. S J Parekh 2. Mr. Surendra Somani 3. Mr. C L Jain 4. Mr. Vijay Bhatia 5. Mr. Sen Hong Fang. Further, the following persons have been appointed as Additional Directors on the Board. 1. Mr. Raman Sharma. 2. Mr. Hardeep Sachdeva. The company has received their consent to act as Directors.

2004

-KDL Biotech Ltd has informed that Dr. Adil P. Dehnugara's resignation from the office of Managing Director has been accepted by the Board at its meeting held on January 30, 2004. He shall vacate the office of Managing Director on the close of business hours of February 29, 2004. However, he will continue to be a Director of the Company.

2007
- Kdl Biotech Limited has appointed Mr. Dr. Rajesh Agrawal as additional director on the board with effect from 26th April, 2007.

2009
-Company has created Email Id for registering the Complaints by the investors n_das@kdlbiotech.in.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article